Invizius

📍 Motherwell, United Kingdom🗓 Founded 2018👥 15 employees💰 Last funded Apr 2023
Medical Equipment Manufacturing🌐 invizius.com
Website LinkedIn
Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland. Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with Acute Kidney Injury receiving CRRT and patient on Renal replacement Therapy receiving Peritoneal Dialysis. Despite significant improvements in haemodialysis membranes Complement activation by contact with a foreign surface remains a serious issue with short, medium and long term clinical implications. Complement activation has also been associated with Peritoneal Dialysis(PD) and may be a driver of fibrotic changes that limit PD duration.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United Kingdom
3
Belgium
1
France
1
Investor activity2019–2023 · investors recorded per year
201932021120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Invizius?
Invizius has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Invizius last raise funding?
The most recent investment in Invizius recorded on gritt.io was in April 2023.
When was Invizius founded?
Invizius was founded in 2018.
What industry is Invizius in?
Invizius operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Invizius based?
Invizius is headquartered in Motherwell, United Kingdom.